Comparative analysis of clinical efficacy and adverse reactions of Peg interferon alfa-2a in combination with ribavirin in the treatment of patients with chronic hepatitis C and hepatitis C cirrhosis at compensation stage

Military Medicine of Joint Logistics ›› 2014, Vol. 28 ›› Issue (08) : 743-747.

PDF(691 KB)
PDF(691 KB)
Military Medicine of Joint Logistics ›› 2014, Vol. 28 ›› Issue (08) : 743-747.

Comparative analysis of clinical efficacy and adverse reactions of Peg interferon alfa-2a in combination with ribavirin in the treatment of patients with chronic hepatitis C and hepatitis C cirrhosis at compensation stage

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2014, 28(08): 743-747

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(691 KB)

Accesses

Citation

Detail

Sections
Recommended

/